S12 E01 Report Back From SABCS 2025: Key Clinical Trial Updates in MBC
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
S12 E01 Report Back From SABCS 2025: Key Clinical Trial Updates in MBC
-
ナレーター：
-
著者：
Send us Fan Mail
What do the latest findings from the 2025 San Antonio Breast Cancer Symposium mean for people living with metastatic breast cancer?
In this episode, Dr. Bora Lim of MD Anderson Cancer Center joins us to break down the most impactful research and clinical trial updates from SABCS 2025. Together we will explore advances in hormone receptor positive, HER2-positive disease and triple negative disease and discuss how these updates may influence treatment decisions right now. We also wrap up with an audience Q&A, including questions about GLP-1 medications.
Listen in for expert insight, practical takeaways, and clarity on the evolving MBC treatment landscape.
We’re so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you’d like us to cover? Email us at ourmbclife@sharecancersupport.org. And don’t forget to follow us on our socials @ourmbclife.
Remember you are not alone.